Fig. 2 –

Urinary incontinence by risk and treatment modality. Urinary incontinence trajectories were adjusted for patient age at diagnosis, comorbidity tumor characteristics (PSA corrected for 5α-reductase inhibitor use, Gleason score [≤6, 3 + 4, 4 + 3, or ≥8], and T stage [T1 or T2]), psychosocial measures (educational attainment, insurance type, employment type, marital status, Short Form-36 physical function score, social support, CES-D score, and participatory decision-making index [16]), and study site. CES-D = Center for Epidemiologic Studies Depression Scale; EBRT = external beam radiotherapy; EPIC = expanded prostate index composite; PSA = prostate specific antigen; RP = radical prostatectomy.